Symbolic analysis detects alterations of cardiac autonomic modulation in congestive heart failure rats

Autonomic Neuroscience: Basic and Clinical

Volumn 150, Issue 1-2, 2009, Pages 21-26

  Tobaldini, Eleonora ^a   Porta, Alberto ^b   Wei, Shun Guang ^c   Zhang, Zhi Hua ^c   Francis, Joseph ^d   Casali, Karina Rabello ^e   Weiss, Robert M ^c,f   Felder, Robert B ^c,f   Montano, Nicola ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF IOWA   (United States)

^d LOUISIANA STATE UNIVERSITY   (United States)

^e FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Autonomic nervous system; Congestive heart failure; Non linear dynamics

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; HEART FUNCTION; HEART RATE VARIABILITY; MALE; NONHUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RAT; SYMPATHETIC TONE;

ANALYSIS OF VARIANCE; ANIMALS; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ELECTROCARDIOGRAPHY; HEART CONDUCTION SYSTEM; HEART FAILURE; HEART RATE; MODELS, CARDIOVASCULAR; RATS; SPECTRUM ANALYSIS; TIME FACTORS;

EID: 69449084261     PISSN: 15660702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autneu.2009.03.009     Document Type: Article

References (45)

1. Anker S.D. Catecholamine levels and treatment in chronic heart failure. Eur. Heart J. 19 (1998) 56-61
2. Bristow M.R., Ginsburg R., Minobe W., Cubicciotti R.S., Sageman W.S., Lurie K., Billingham M.E., Harrison D.C., and Stinson E.B. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N. Engl. J. Med. 307 (1982) 205-211
3. Cohn N.J., and Yellin A.M. Learned precise cardiovascular control through graded central sympathetic modulation. J. Hyperten. 2 (1984) 77-79
4. Deswal A., Petersen N.J., Feldman A.M., Young J.B., White B.G., and Mann D.L. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 103 (2001) 2055-2059
5. Dias Da Silva V.J., Gnecchi-Ruscone T., Lavelli B., Bellina V., Manzella D., Porta A., Malliani A., and Montano N. Opposite effects of iv amiodarone on cardiovascular vagal and sympathetic efferent activities in rats. Am. J. Physiol. 283 (2002) 543-548
6. Dzau V.J., Colucci W.S., Hollenberg N.K., and Williams G.H. Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation 63 (1981) 645-651
7. Eaton G.M., Cody R.J., Nunziata E., and Binkley P.F. Early left ventricular dysfunction elicits activation of sympathetic drive and attenuation of parasympathetic tone in the paced canine model of congestive heart failure. Circulation 92 (1995) 555-561
8. Esler M., and Kaye D. Measurements of sympathetic nervous system activity in heart failure: the role of norepinephrine kinetics. Heart Fail. Rev. 5 (2000) 17-25
9. Ferguson D.W., Berg W.J., Roach P.J., Oren R.M., and Mark A.L. Effects of heart failure on baroreflex control of sympathetic neural activity. Am. J. Cardiol. 69 (1992) 523-531
10. Floras J.S. The "unsympathetic" nervous system of heart failure. Circulation 105 (2002) 1753-1755
11. Francis G.S. Extracardiac features of heart failure: catecholamines and hormonal changes. Cardiology 75 (1988) 19-29
12. Francis G.S. Plasma BNP concentration predicted the presence of heart failure. Evid. Based. Cardiovasc. Med. 2 (1998) 55-56
13. Francis J., Weiss R., Wei S.G., Johnson A.K., and Felder R.B. Progression of heart failure after myocardial infarction in the rat. Am. J. Physiol. 281 (2001) 1734-1745
14. Francis J., Weiss R.M., Wei S.G., Johnson A.K., Beltz T.G., Zimmerman K., and Felder R.B. Central mineralocorticoid receptor blockade improves volume regulation and reduces sympathetic drive in heart failure. Am. J. Physiol. 281 (2001) H2241-H2251
15. Francis J., Wei S.G., Weiss R.M., Johnson A.K., and Felder R.B. Central but not peripheral infusion of mineralocorticoid receptor antagonist decreases sympathetic drive early after coronary artery ligation in rats. FASEB J. 16 (2002) A791
16. Grassi G., Seravalle G., Cattaneo B.M., Lanfranchi A., Vailati S., Giannattasio C., Del Bo A., Sala C., Bolla G.B., and Pozzi M. Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. Circulation 92 (1995) 3206-3211
17. Gullestad L., and Aukrust P. The cytokine network in heart failure: pathogenetic importance and potential therapeutic targets. Heart Fail. Monitor. 2 (2001) 8-13
18. Guzzetti S., Cogliati C., Turiel M., Crema C., Lombardi F., and Malliani A. Sympathetic predominance followed by functional denervation in the progression of chronic heart failure. Eur. Heart J. 16 (1995) 1100-1107
19. Guzzetti S., Magatelli R., Borroni E., and Mezzetti S. Heart rate variability in chronic heart failure. Auton. Neurosci.: Basic Clin. 91 (2001) 102-105
20. Guzzetti S., Borroni E., Garbelli P.E., Ceriani E., Della Bella P., Montano N., Cogliati C., Somers V.K., Malliani A., and Porta A. Symbolic dynamics of heart rate variability: a probe to investigate cardiac autonomic modulation. Circulation 112 (2005) 465-470
21. Hasking G.J., Esler M.D., Jennings G.L., Burton D., Johns J.A., and Korner P.I. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous system activity. Circulation 73 (1986) 615-621
22. Ishise H., Asanoi H., Ishizaka S., Joho S., Kameyama T., Umeno K., and Inoue H. Time course of sympathovagal imbalance and left ventricular dysfunction in conscious dogs with heart failure. J. Appl. Physiol. 84 (1998) 1234-1241
23. Kang Y.M., Zhang Z.H., Johnson R.F., Yu Y., Beltz T., Johnson A.K., Weiss R.M., and Felder R.B. Novel effect of mineralocorticoid receptor antagonism to reduce proinflammatory cytokines and hypothalamic activation in rats with ischemia-induced heart failure. Circulation Res. 99 (2006) 758-766
24. Kjaer A., and Hesse B. Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives. Clin. Physiol. 21 (2001) 661-672
25. Kodama M., Hirono S., Hanawa H., Yoshida T., Hayashi M., Tachikawa H., Kashimura T., Watanabe K., and Aizawa Y. Linkage between mechanical and electrical alternans in patients with chronic heart failure. J. Cardiovasc. Electrophysiol. 15 (2004) 295-299
26. Kruger C., Kalenka A., Haunstetter A., Schweizer M., Maier G., Ruhle U., Ehmke H., Kubler W., and Haass M. Baroreflex sensitivity and heart rate variability in conscious rats with myocardial infarction. Am. J. Physiol. 273 (1997) 2240-2247
27. La Rovere M.T., Pinna G.D., Maestri R., Mortara A., Capomolla S., Febo O., Ferrari R., Franchini M., Gnemmi M., Opasich C., Riccardi P.G., Traversi E., and Cobelli F. Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation 107 (2003) 565-570
28. Leimbach W.N., Wallin B.G., Victor R.G., Aylward P.E., Sundlof G., and Mark A.L. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation 73 (1986) 913-919
29. Lohse M.J., Engelhardt S., and Eschenhagen T. What is the role of beta-adrenergic signaling in heart failure?. Circ. Res. 93 (2003) 896-906
30. Maestri R., Pinna G.D., Accardo A., Allegrini P., Balocchi R., D'addio G., Ferrario M., Menicucci D., Porta A., Sassi R., Signorini M.G., La Rovere M.T., and Cerutti S. Nonlinear indices of heart rate variability in chronic heart failure patients: redundancy and comparative clinical value. J. Cardiovasc. Electrophysiol. 18 (2007) 425-433
31. Malliani A., and Pagani M. The role of the sympathetic nervous system in congestive heart failure. Eur. Heart J. 4 (1983) 49-54
32. Malliani A., and Montano N. Emerging excitatory role of cardiovascular sympathetic afferents in pathophysiological conditions. Hypertension 39 (2002) 63-68
33. Malliani A., Pagani M., Lombardi F., and Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation 84 (1991) 482-492
34. Middlekauff H.R., and Mark A.L. The treatment of heart failure: the role of neurohumoral activation. Intern. Med. 37 (1998) 112-122
35. Motte S., Mathieu M., Brimioulle S., Pensis A., Ray L., Ketelslegers J.M., Montano N., Naeije R., Van De Borne P., and Entee K.M. Respiratory-related heart rate variability in progressive experimental heart failure. Am. J. Physiol. 289 (2005) 1729-1735
36. Pagani M., Somers V.K., Furlan R., Dell'orto S., Conway J., Baselli G., Cerutti S., Sleight P., and Malliani A. Changes in autonomic regulation induced by physical training in mild hypertension. Hypertension 12 (1988) 600-610
37. Petersen J.W., and Felker G.M. Inflammatory biomarkers in heart failure. Congest Heart Fail. 12 (2006) 324-328
38. Porta A., Guzzetti S., Montano N., Furlan R., Malliani A., and Cerutti S. Entropy, entropy rate and pattern classification as tools to typify complexity in short heart period variability series. IEEE Trans. Biomed. Eng. 48 (2001) 1282-1291
39. Porta A., Furlan R., Rimoldi O., Pagani M., Malliani A., and Van De Borne P. Quantifying the strength of the linear causal coupling in closed loop interacting cardiovascular variability signals. Biol. Cybern. 86 (2002) 241-251
40. Porta A., Faes L., Masé M., D'addio G., Pinna G.D., Maestri R., Montano N., Furlan R., Guzzetti S., Nollo G., and Malliani A. An integrated approach based on uniform quantization for the evaluation of complexity of short-term heart period variability: application to 24h Holter recordings in healthy and heart failure humans. Chaos 17 (2007) 015117
41. Porta A., Tobaldini E., Guzzetti S., Furlan R., Montano N., and Gnecchi-Ruscone T. Assessment of cardiac autonomic modulation during graded head-up tilt by symbolic analysis of heart rate variability. Am. J. Physiol. 293 (2007) H702-H708
42. Task force of the European Society of cardiology and the north American Society of pacing and electrophysiology. Standard of measurement, physiological interpretation and clinical use. Circulation 93 (1996) 1043-1065
43. Van De Borne P., Montano N., Pagani M., Oren R., and Somers V.K. Absence of low-frequency variability of sympathetic nerve activity in severe heart failure. Circulation 95 (1997) 1449-1454
44. Watson A.M., Hood S.G., and May C.N. Mechanisms of sympathetic activation in heart failure. Clin. Exp. Pharmacol. Physiol. 33 (2006) 1269-1274
45. Zucker I.H. Novel mechanisms of sympathetic regulation in chronic heart failure. Hypertension 48 (2006) 1005-1011